TWO · —

Welgene Biotech Co.,Ltd. (6661.TWO) Stock

$17.30 +1.76% TWO: 6661.TWO —

—

Valuation

MetricValue
Price$17.30
Market Cap$386.85M
P/E Ratio—
P/B Ratio1.42
P/S Ratio0.97
EPS (TTM)$-0.06
52-Week High$20.35
52-Week Low$15.50
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-0.49%
ROA-0.26%
ROCE—
Gross Margin41.83%
Operating Margin-1.19%
Net Margin-0.41%
Debt/Equity1.01
Current Ratio1.91

About Welgene Biotech Co.,Ltd.

—

Welgene Biotech Co.,Ltd. is led by CEO Yi Xing Lin, employs 80 people, headquartered in Taipei, TW, publicly traded since 2017.

Welgene Biotech Co.,Ltd. (6661.TWO) stock trades at $17.30 with a market capitalization of $386.85M. The stock is valued at price-to-book of 1.42, price-to-sales of 0.97. Over the past 52 weeks the stock has ranged between $15.50 and $20.35, and currently trades 15.0% below its 52-week high.

On profitability, Welgene Biotech Co.,Ltd. generates a return on equity (ROE) of -0.49% (negative, reflecting a net loss), an operating margin of -1.19%, a net profit margin of -0.41%.

Official website: www.welgene.com.tw

Welgene Biotech Co.,Ltd. (6661.TWO) — frequently asked questions

What is Welgene Biotech Co.,Ltd. (6661.TWO) stock price today?

Welgene Biotech Co.,Ltd. (6661.TWO) is currently trading at $17.30, up 1.76% today.

What is 6661.TWO return on equity (ROE)?

Welgene Biotech Co.,Ltd.'s return on equity (ROE) is -0.49%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is Welgene Biotech Co.,Ltd.'s market cap?

Welgene Biotech Co.,Ltd. has a market capitalization of $386.85M.

Does 6661.TWO pay a dividend?

Welgene Biotech Co.,Ltd. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does 6661.TWO carry?

Welgene Biotech Co.,Ltd. has a debt-to-equity ratio of 1.01. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is 6661.TWO's profit margin?

Welgene Biotech Co.,Ltd. reports a net profit margin of -0.41% — the share of revenue left after every cost, including tax and interest.

What sector is 6661.TWO in?

Welgene Biotech Co.,Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is 6661.TWO listed on?

Welgene Biotech Co.,Ltd. trades on TWO under the ticker 6661.TWO.

What is 6661.TWO's 52-week range?

Over the last year Welgene Biotech Co.,Ltd. has traded between $15.50 and $20.35.

Related — Stocks

HONA Honeywell Aerospace Inc. $167.90 -0.44% USDE StablecoinX Inc. $1.00 -0.01% SSMR Sunshine Silver Mining & Refining Company $14.18 +8.33% GENB Generate Biomedicines, Inc. $13.21 +6.96% PURR Hyperliquid Strategies Inc $9.85 +8.60% HAWK HawkEye 360, Inc. $13.52 +5.96% SPTX Seaport Therapeutics, Inc. $21.28 +2.16% HBNB Hotel101 Global Holdings Corp. $4.77 +7.98% WHK WhiteHawk Minerals Corp $26.81 +2.92% GMRS GMR Solutions Inc. $10.66 -1.39% AGMB AgomAb Therapeutics NV - ADRs representing one common share. $8.40 -1.98% DYNC Dynamix Corporation - Class A Ordinary Share $10.91 +0.32%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens 6661.TWO currently matches

On the figures above, Welgene Biotech Co.,Ltd. passes the filters for 3 of our ready-made screens, among them Small Cap Stocks, Stocks Under $100, Stocks Under $50. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Small Cap StocksStocks Under $100Stocks Under $50

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.